Literature DB >> 630809

A radioimmunoassay for 1,25-dihydroxycholecalciferol.

T L Clemens, G N Hendy, R F Graham, E G Baggiolini, M R Uskokovic, J L O'Riordan.   

Abstract

1. 1alpha,25-Dihydroxy-25-hemisuccinate cholecalciferol has been synthesized and conjugated to bovine serum albumin. 2. This conjugate is immunogenic; when injected into rabbits antibodies of high affinity for 1alpha,25-dihydroxycholecalciferol were obtained. 3. Vitamin D metabolites lacking the 1alpha-hydroxy group were of lower cross-reactivity with the antibodies. 4. By using these antibodies and 1alpha,25-[23,24-3H]dihydroxycholecalciferol as tracer a sensitive radioimmunoassay has been developed capable of detecting 20 pg of 1alpha,25-dihydroxycholecalciferol.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 630809     DOI: 10.1042/cs0540329

Source DB:  PubMed          Journal:  Clin Sci Mol Med        ISSN: 0301-0538


  9 in total

1.  The assessment of circulating 25(OH)D and 1,25(OH)2D: where we are and where we are going.

Authors:  Bruce W Hollis; Ronald L Horst
Journal:  J Steroid Biochem Mol Biol       Date:  2007-01-02       Impact factor: 4.292

Review 2.  The clinical use of vitamin D metabolites and their potential developments: a position statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF).

Authors:  Luisella Cianferotti; Claudio Cricelli; John A Kanis; Ranuccio Nuti; Jean-Y Reginster; Johann D Ringe; Rene Rizzoli; Maria Luisa Brandi
Journal:  Endocrine       Date:  2015-05-01       Impact factor: 3.633

3.  Regulation of human tonsillar T-cell proliferation by the active metabolite of vitamin D3.

Authors:  J D Nunn; D R Katz; S Barker; L J Fraher; M Hewison; G N Hendy; J L O'Riordan
Journal:  Immunology       Date:  1986-12       Impact factor: 7.397

Review 4.  Assessment and interpretation of circulating 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D in the clinical environment.

Authors:  Bruce W Hollis
Journal:  Endocrinol Metab Clin North Am       Date:  2010-06       Impact factor: 4.741

5.  Metabolism of 25-hydroxyvitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis.

Authors:  J S Adams; O P Sharma; M A Gacad; F R Singer
Journal:  J Clin Invest       Date:  1983-11       Impact factor: 14.808

6.  Serum concentrations of vitamin D metabolites in untreated tuberculosis.

Authors:  P D Davies; R C Brown; J S Woodhead
Journal:  Thorax       Date:  1985-03       Impact factor: 9.139

7.  Treatment of bone disease after jejunoileal bypass for obesity with oral 1 alpha-hydroxyvitamin D3.

Authors:  J E Compston; L W Horton; M F Laker; A L Merrett; J S Woodhead; J C Gazet; T R Pilkington
Journal:  Gut       Date:  1980-08       Impact factor: 23.059

8.  Vitamin D Deficiency and Its Health Consequences in Africa.

Authors:  Ann Prentice; Inez Schoenmakers; Kerry S Jones; Landing M A Jarjou; Gail R Goldberg
Journal:  Clin Rev Bone Miner Metab       Date:  2009

9.  There is more to life than serum vitamin D: a lesson from the past.

Authors:  Martin Hewison
Journal:  Clin Sci (Lond)       Date:  2022-04-29       Impact factor: 6.876

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.